FDA — authorised 7 April 2009
- Application: NDA022268
- Marketing authorisation holder: NOVARTIS
- Status: supplemented
FDA authorised Coartem on 7 April 2009
Yes. FDA authorised it on 7 April 2009; FDA has authorised it.
NOVARTIS holds the US marketing authorisation.